This website uses cookies to enhance the user experience.
HH

Håvard Hildeng Hauge1969

Shareholdings
8
2
Norway Business roles
9

Roles

Management

NameRoleTotal operating incomeTotal equityShares
B
BIOMOLEX AS
Managing Director/CEO
2,515,404
156,837
11.3 %
indirectly
P
PUBGENE AS
Managing Director/CEO
11,634,488
11,626,306
-

Boards

NameRoleTotal operating incomeTotal equityShares
C
CEROLU AS
Contact Person
363,000
746,894
100 %
directly
B
BIOMOLEX AS
Board Member
2,515,404
156,837
11.3 %
indirectly
C
COREMINE VITAE AS
Board Member
2,259,385
1,763,479
6.78 %
directly 6.15 %
indirectly 0.63 %
V
VITAE EVIDENCE AS
Chairman
1,286,300
6,000,092
6.5 %
directly 5.46 %
indirectly 1.04 %
C
COREMINE BIL
Board Member
-
-
-
P
PUBGENE AS
Board Member
11,634,488
11,626,306
-
Last update: Aug 17, 2023

Related industries3

  • Professional, scientific and technical activities
  • Arts, entertainment and recreation
  • Information and communication

Direct relationships5

Shares owned by Håvard Hildeng Hauge

NameShare classTotal operating incomeTotal equityShare
C
CEROLU AS
Ordinære aksjer
363,000
746,894
100 %
directly
B
BIOMOLEX AS
2,515,404
156,837
11.3 %
indirectly
C
COREMINE VITAE AS
Ordinære aksjer
2,259,385
1,763,479
6.15 %
directly 6.15 %
indirectly 0.63 %
V
VITAE EVIDENCE AS
Ordinære aksjer
1,286,300
6,000,092
5.46 %
directly 5.46 %
indirectly 1.04 %
A
ARCTIC PHARMA AS
5,291,365
3,383,767
2.93 %
indirectly
S
SVINGEN - PÅ SLETTA - AS
Ordinære aksjer
2,517,050
-244
2.37 %
directly
R
RHEUMATECH AS
Ordinære aksjer
179,900
341,910
1.16 %
directly
A
AIRTHINGS ASA
NO0010895568
358,046,000
499,499,000
0.8 %
directly
F
FLYR AS
NO0010931900
125,939,000
163,919,000
< 0.01 %
directly
S
SPERMATECH AS
NO0010291057
2,715,248
1,216,525
< 0.01 %
directly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024